Literature DB >> 18241247

Messenger RNA expression of monocyte chemoattractant protein-1 and interleukin-6 in stone-containing kidneys.

Chanchai Boonla1, Chanutra Hunapathed, Sombat Bovornpadungkitti, Kanitta Poonpirome, Kriang Tungsanga, Pichet Sampatanukul, Piyaratana Tosukhowong.   

Abstract

OBJECTIVES: To investigate the intrarenal mRNA expression of monocyte chemoattractant protein-1 (MCP-1) and interleukin-6 (IL-6) in patients with nephrolithiasis, and to evaluate whether their expression is associated with renal function, as oxidative stress and inflammation are involved in the pathogenesis of nephrolithiasis. PATIENTS, SUBJECTS AND METHODS: Renal biopsies from near the stone, and blood and 24-h urine specimens were collected from 29 patients with nephrolithiasis. Control renal tissues were taken from non-cancerous and cancerous portions of nephrectomy from six patients with renal cancers, and control 24-h urine samples were obtained from 30 healthy subjects. Corrected creatinine clearance, urinary N-acetyl-beta-glucosaminidase activity and 8-hydroxy-deoxyguanosine (8-OHdG) were determined. The mRNA expressions of MCP-1 and IL-6 in the tissues were measured by real time reverse transcription-polymerase chain reaction.
RESULTS: Patients with nephrolithiasis had significantly greater renal tubular damage and oxidative stress than the healthy controls. Intrarenal mRNA expressions of MCP-1 and IL-6 in stone-adjacent renal tissues were significantly lower than in cancerous renal tissues, but not statistically different from that in non-cancerous renal tissues. In stone-adjacent renal tissues, the mRNA level of MCP-1 was significantly higher than that of IL-6, but their expressions were significantly correlated with each other. Histological examination showed that the number of infiltrated leukocytes corresponded well with the intrarenal mRNA levels of MCP-1 and IL-6. Patients with nephrolithiasis and compromised renal function had significantly higher intrarenal mRNA levels of MCP-1 and IL-6 than those with preserved renal function. Also, the mRNA levels in patients with severe renal tubular damage were significantly greater than in those with less renal tubular damage. There was no association between intrarenal mRNA expression and urinary 8-OHdG.
CONCLUSION: Nephrolithiasis was associated with low-grade intrarenal inflammation. A greater intrarenal mRNA expression of MCP-1 and IL-6 was associated with enhanced renal impairment. Thus, expression of MCP-1 and IL-6, at least in part, contributed to the progression of nephrolithiasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18241247     DOI: 10.1111/j.1464-410X.2008.07461.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  22 in total

1.  Lithogenic activity and clinical relevance of lipids extracted from urines and stones of nephrolithiasis patients.

Authors:  Chanchai Boonla; Phantip Youngjermchan; Somkiat Pumpaisanchai; Kriang Tungsanga; Piyaratana Tosukhowong
Journal:  Urol Res       Date:  2010-05-28

2.  Urinary MCP-1、HMGB1 increased in calcium nephrolithiasis patients and the influence of hypercalciuria on the production of the two cytokines.

Authors:  Yang Wang; Chun Sun; Chengyang Li; Yaoliang Deng; Guohua Zeng; Zhiwei Tao; Xiang Wang; Xiaofeng Guan; Yutong Zhao
Journal:  Urolithiasis       Date:  2016-07-08       Impact factor: 3.436

3.  Increased oxidative DNA damage seen in renal biopsies adjacent stones in patients with nephrolithiasis.

Authors:  Wipawee Kittikowit; Uraiwan Waiwijit; Chanchai Boonla; Preecha Ruangvejvorachai; Chaowat Pimratana; Chagkrapan Predanon; Supoj Ratchanon; Piyaratana Tosukhowong
Journal:  Urolithiasis       Date:  2014-07-15       Impact factor: 3.436

4.  Clcn5 knockout mice exhibit novel immunomodulatory effects and are more susceptible to dextran sulfate sodium-induced colitis.

Authors:  Philip Alex; Mei Ye; Nicholas C Zachos; Jennifer Sipes; Thuan Nguyen; Maxim Suhodrev; Liberty Gonzales; Zubin Arora; Ting Zhang; Michael Centola; Sandra E Guggino; Xuhang Li
Journal:  J Immunol       Date:  2010-02-24       Impact factor: 5.422

5.  In vitro anti-lithogenic activity of lime powder regimen (LPR) and the effect of LPR on urinary risk factors for kidney stone formation in healthy volunteers.

Authors:  Pajaree Chariyavilaskul; Poonsin Poungpairoj; Suchada Chaisawadi; Chanchai Boonla; Thasinas Dissayabutra; Phisit Prapunwattana; Piyaratana Tosukhowong
Journal:  Urolithiasis       Date:  2015-01-15       Impact factor: 3.436

6.  rs11567842 SNP in SLC13A2 gene associates with hypocitraturia in Thai patients with nephrolithiasis.

Authors:  Pattarin Udomsilp; Sarawut Saepoo; Rungnapa Ittiwut; Vorasuk Shotelersuk; Thasinas Dissayabutra; Chanchai Boonla; Piyaratana Tosukhowong
Journal:  Genes Genomics       Date:  2018-05-17       Impact factor: 1.839

7.  Experimentally induced hyperoxaluria in MCP-1 null mice.

Authors:  Saeed R Khan; Patricia A Glenton
Journal:  Urol Res       Date:  2010-12-16

8.  Gallotannin suppresses calcium oxalate crystal binding and oxalate-induced oxidative stress in renal epithelial cells.

Authors:  Hyo-Jung Lee; Soo-Jin Jeong; Moon Nyeo Park; Michael Linnes; Hee Jeoung Han; Jin Hyoung Kim; John Charles Lieske; Sung-Hoon Kim
Journal:  Biol Pharm Bull       Date:  2012       Impact factor: 2.233

9.  Is urolithiasis associated with increased levels of high sensitivity C-reactive protein and interleukin-6 in diabetic patients?

Authors:  Aysha Hasna; Kavitha Meiyappan; Senthilkumar Gandhipuram Periyasam; Muruganandham Kalyaperumal; Zachariah Bobby; Arul Vijaya Vani Subramaniam
Journal:  J Clin Diagn Res       Date:  2015-03-01

10.  Monocyte Mitochondrial Function in Calcium Oxalate Stone Formers.

Authors:  Jennifer Williams; Ross P Holmes; Dean G Assimos; Tanecia Mitchell
Journal:  Urology       Date:  2016-03-10       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.